Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients
about
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathyRisk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy.Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability.Management of hypertrophic cardiomyopathy."Burnt out" dilated hypertrophic cardiomyopathy causing acute LVAD thrombosis.Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at higClinical Characteristics and Prognosis of End-stage Hypertrophic CardiomyopathyNext generation sequencing-based copy number analysis reveals low prevalence of deletions and duplications in 46 genes associated with genetic cardiomyopathies.Altered regional cardiac wall mechanics are associated with differential cardiomyocyte calcium handling due to nebulette mutations in preclinical inherited dilated cardiomyopathy.Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesNuclear cardiac imaging in hypertrophic cardiomyopathy.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.Findings of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy after 16 Years.Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.Outcomes of Berlin Heart EXCOR® pediatric ventricular assist device support in patients with restrictive and hypertrophic cardiomyopathy.Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis.Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity.The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.Prognostic indicators in cats with hypertrophic cardiomyopathy.Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmiaClinical presentations of hypertrophic cardiomyopathy and implications for therapy
P2860
Q28252486-5941A37D-1967-4751-957A-B101DC883AE8Q33158326-0A35C406-3924-464F-ADD5-739CE24FDFD8Q33763883-2E0FF878-DC2F-494D-9815-36AA3F9FBECBQ33831632-49CB178F-271A-4679-9003-9CA396D6767EQ34095709-2F79EE7A-F692-448B-83CC-6F3DB01217C3Q34214905-0E4CF9B5-D4E5-43FB-8626-03C98246F57CQ34273479-44BB821B-30AC-4624-AA11-85EA8D1C4C26Q34428462-E352A835-45BC-4721-8883-FAEE50C5AA4BQ34647057-E81782C7-3D66-48F0-B01E-410EE1192B37Q35841776-0B117869-FFBB-4041-9754-AF418464AD99Q36156912-792582D8-9773-4B8D-A6AB-B89ED087A5FDQ36523287-BDBB44DD-8512-4596-8537-344B4B050A85Q36706648-329AD1C7-491C-4BD6-8534-B554AB525164Q36932655-07EB9CF0-F38B-4082-9021-38CD17484609Q37061992-D5423138-FC55-46FF-ACF5-5657B836D81FQ37782285-B56968B4-0B6A-48B6-85AE-D4ACA532EDC1Q38336102-2B18609C-B8E3-40FB-B454-A564F2A4B879Q38343713-D7221383-09D3-41A1-951A-4109C2EA11C6Q38410021-739D3FD7-891B-45ED-921D-AED5AB7DFA8FQ38417406-084B44E2-92BD-4762-95E4-7EF5F5B5ACB2Q40047064-9DEF95C6-966E-45B4-ACB0-D92C7420C927Q40503224-E55D5800-2C54-4BB9-831D-0699D5CA7EA6Q41696597-F8A1FD3B-27AA-4779-85B4-B0F503DFB479Q41936884-36496DC6-35C8-4BEE-A756-06B94FA8992DQ43962585-3CB8D88D-060C-441D-944A-8C45193993EAQ44492573-E203D618-7439-4711-B71B-979E5BEF365BQ45788044-B16F98FA-17DA-4CD0-9F8D-644A6B949FF2Q48360401-804CBB49-1247-43E1-9473-19AB846A422BQ50086129-9FA46609-7048-445A-9D56-C982B7E01FE4Q51759829-EB90AF00-7EA9-4D34-8238-C975E9F613FFQ58565572-583172A3-FD85-4841-B705-C244A96FEB94Q58565625-70EB2A68-0BC8-4A5C-AAC5-BE0F4AB3F73B
P2860
Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients
description
im Oktober 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 September 2005
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2005
@uk
name
Dilated-hypokinetic evolution ...... n pediatric and adult patients
@en
Dilated-hypokinetic evolution ...... n pediatric and adult patients
@nl
type
label
Dilated-hypokinetic evolution ...... n pediatric and adult patients
@en
Dilated-hypokinetic evolution ...... n pediatric and adult patients
@nl
prefLabel
Dilated-hypokinetic evolution ...... n pediatric and adult patients
@en
Dilated-hypokinetic evolution ...... n pediatric and adult patients
@nl
P2093
P50
P1476
Dilated-hypokinetic evolution ...... n pediatric and adult patients
@en
P2093
Angelo Branzi
Carla Lofiego
Daniela Prandstraller
Enrica Perugini
Fabio Coccolo
Fernando M Picchio
Guido Rocchi
Marinella Ferlito
P304
P356
10.1016/J.JACC.2005.04.062
P407
P577
2005-09-28T00:00:00Z